Emerald Health Pharmaceuticals Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Emerald Health Pharmaceuticals General Information

Description

Developer of medical drug products intended for the treatment of inflammatory, autoimmune, and neurodegenerative diseases. The company has created two families of new chemical entities, derived from synthetic cannabidiol and cannabigerol, enabling doctors to address unmet medical needs in the treatment of multiple diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11250 El Camino Real
  • Suite 100
  • San Diego, CA 92130
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 11250 El Camino Real
  • Suite 100
  • San Diego, CA 92130
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Emerald Health Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Clinical Trials - Phase 2
4. Early Stage VC 08-Jul-2021 Completed Clinical Trials - Phase 2
3. Equity Crowdfunding 28-Mar-2021 Completed Clinical Trials - Phase 2
2. Early Stage VC 25-Mar-2019 $12.7M $12.7M Completed Clinical Trials - Phase 1
1. Angel (individual) 14-Mar-2017 $1K $1K Completed Startup
To view Emerald Health Pharmaceuticals’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Emerald Health Pharmaceuticals Patents

Emerald Health Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3167135-A1 Composition and method for the treatment and prevention of cardiac, pulmonary, dermal, and renal fibrosis Pending 06-Feb-2020
EP-4099993-A1 Composition and method for the treatment and prevention of cardiac, pulmonary, dermal, and renal fibrosis Inactive 06-Feb-2020
EP-4099993-A4 Composition and method for the treatment and prevention of cardiac, pulmonary, dermal, and renal fibrosis Inactive 06-Feb-2020
US-20230137092-A1 Composition and method for the treatment and prevention of cardiac, pulmonary, dermal, and renal fibrosis Inactive 06-Feb-2020
WO-2021159059-A1 Composition and method for the treatment and prevention of cardiac, pulmonary, dermal, and renal fibrosis Inactive 06-Feb-2020 A61K31/122
To view Emerald Health Pharmaceuticals’s complete patent history, request access »

Emerald Health Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Emerald Health Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Emerald (Pharmaceuticals and Biotechnology) Corporation Minority
Ray Family Company Holdings Family Office Minority
To view Emerald Health Pharmaceuticals’s complete investors history, request access »

Emerald Health Pharmaceuticals Investments (1)

Emerald Health Pharmaceuticals’s most recent deal was a Seed Round with Prima for . The deal was made on 21-May-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Prima 21-May-2021 Seed Round Personal Products
To view Emerald Health Pharmaceuticals’s complete investments history, request access »

Emerald Health Pharmaceuticals FAQs

  • When was Emerald Health Pharmaceuticals founded?

    Emerald Health Pharmaceuticals was founded in 2017.

  • Where is Emerald Health Pharmaceuticals headquartered?

    Emerald Health Pharmaceuticals is headquartered in San Diego, CA.

  • What is the size of Emerald Health Pharmaceuticals?

    Emerald Health Pharmaceuticals has 13 total employees.

  • What industry is Emerald Health Pharmaceuticals in?

    Emerald Health Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Emerald Health Pharmaceuticals a private or public company?

    Emerald Health Pharmaceuticals is a Private company.

  • What is Emerald Health Pharmaceuticals’s current revenue?

    The current revenue for Emerald Health Pharmaceuticals is .

  • How much funding has Emerald Health Pharmaceuticals raised over time?

    Emerald Health Pharmaceuticals has raised $69.5M.

  • Who are Emerald Health Pharmaceuticals’s investors?

    Emerald (Pharmaceuticals and Biotechnology) and Ray Family Company Holdings have invested in Emerald Health Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process